QMENTA has reduced the costs of MR imaging collection and storage in the trial by approximately 50% and has reduced the site burden by an estimated 75%. Has been a tremendous help keeping our trial on budget and on time."

CSO of Amylyx Pharmaceuticals Kent Leslie

We are using these quantification tools to detect easier which brain regions are damaged and help us find better and personalized treatments for our patients.

Principal Investigator at Hospital Sant Joan de Déu Angels García-Cazorla, MD, PhD

The platform that they provide is a great tool for data management and processing. It is very flexible and efficient, providing quick answers to our research questions.

Systems Biology Program at a large center for genomics investigations Mara Dierssen, MD, PhD

QMENTA solutions fill a significant unmet need for all researchers and clinicians working with imaging. Their diseases packages are going to be extremely useful in clinical practice and for conducting clinical trials developing new drugs for MS

Researcher IDIBAPS; Founder & Scientific Advisor Bionure; Adjunct Professor UCSF Pablo Villoslada Diaz, MD, PhD Senior

QMENTA enables efficient and immediate access to our quantitative imaging solutions to those involved in clinical trials and research. It is exciting to be part of QMENTA’s platform and helping advance the understanding of neurological disorders."

President & CEO at Imaging Biometrics Michael Schmainda

This platform provides a much deeper analysis than we were used to before. With these tools, we can continue to find more significant predictors for success and complications, improving study results and patient quality of life.”

Medical Technology Director, CEDIMAT Director Research, Dominican Gamma Knife Center Herwin Speckter, MSc